Akebia Therapeutics Inc (AKBA)
Cash & Equivalents
$155.55M
Quarterly · Period ending: · USD
AKBA Cash & Equivalents
Latest reported$155.55Mperiod ending
Latest reported$155.55Mperiod ending
AKBA Quarterly Cash & Equivalents ($1.64M → $155.55M)
Quarterly Cash & Equivalents
High-resolution chart · PNG
AKBA cash & equivalents history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 155,548,000 | |
| 162,644,000 | |
| 184,844,000 | |
| 166,444,000 | |
| 137,308,000 | |
| 113,374,000 | |
| 51,870,000 | |
| 34,019,000 | |
| 39,499,000 | |
| 41,961,000 | |
| 42,925,000 | |
| 46,529,000 | |
| 53,572,000 | |
| 56,953,000 | |
| 90,466,000 | |
| 144,761,000 | |
| 143,893,000 | |
| 174,562,000 | |
| 149,800,000 | |
| 207,204,000 | |
| 246,992,000 | |
| 252,765,000 | |
| 229,093,000 | |
| 169,286,000 | |
| 245,406,000 | |
| 115,769,000 | |
| 147,712,000 | |
| 122,886,000 | |
| 87,212,000 | |
| 62,741,000 | |
| 104,644,000 | |
| 162,430,000 | |
| 163,526,000 | |
| 158,171,000 | |
| 70,156,000 | |
| 89,599,000 | |
| 125,390,000 | |
| 87,250,000 | |
| 187,335,000 | |
| 65,830,000 | |
| 46,177,000 | |
| 43,439,000 | |
| 49,778,000 | |
| 66,712,000 | |
| 76,248,000 | |
| 27,887,000 | |
| 32,780,000 | |
| 49,668,000 | |
| 95,394,102 | |
| 126,319,457 | |
| 21,215,228 | |
| 24,603,252 | |
| -1,641,038 | |
| 1,641,038 |